News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
282,370 Results
Type
Article (14943)
Company Profile (299)
Press Release (267122)
Multimedia
Podcasts (78)
Webinars (11)
Section
Business (80030)
Career Advice (163)
Deals (13364)
Drug Delivery (40)
Drug Development (50783)
Employer Resources (31)
FDA (5880)
Job Trends (5219)
News (145464)
Policy (10109)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (2)
Academia (924)
Accelerated approval (19)
Adcomms (14)
Allergies (81)
Alliances (21803)
ALS (124)
Alzheimer's disease (1032)
Antibody-drug conjugate (ADC) (241)
Approvals (6079)
Artificial intelligence (259)
Autoimmune disease (110)
Automation (9)
Bankruptcy (105)
Best Places to Work (4592)
BIOSECURE Act (6)
Biosimilars (101)
Biotechnology (230)
Bladder cancer (101)
Brain cancer (45)
Breast cancer (344)
Cancer (3133)
Cardiovascular disease (237)
Career advice (149)
Career pathing (7)
CAR-T (217)
CDC (5)
Cell therapy (563)
Cervical cancer (14)
Clinical research (43767)
Collaboration (1149)
Company closure (2)
Compensation (591)
Complete response letters (39)
COVID-19 (1102)
CRISPR (86)
C-suite (552)
Cystic fibrosis (113)
Data (4330)
Denatured (15)
Depression (92)
Diabetes (254)
Diagnostics (1381)
Digital health (10)
Diversity (5)
Diversity, equity & inclusion (9)
Drug discovery (187)
Drug pricing (49)
Drug shortages (3)
Duchenne muscular dystrophy (213)
Earnings (31701)
Editorial (25)
Employer branding (4)
Employer resources (29)
Events (51776)
Executive appointments (621)
FDA (7642)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (9)
Frontotemporal dementia (22)
Funding (980)
Gene editing (182)
Generative AI (21)
Gene therapy (486)
GLP-1 (504)
Government (1151)
Grass and pollen (3)
Guidances (166)
Healthcare (6647)
HIV (18)
Huntington's disease (43)
IgA nephropathy (74)
Immunology and inflammation (190)
Immuno-oncology (39)
Indications (67)
Infectious disease (1206)
Inflammatory bowel disease (157)
Inflation Reduction Act (10)
Influenza (38)
Intellectual property (166)
Interviews (18)
IPO (7349)
IRA (12)
Job creations (890)
Job search strategy (129)
JPM (40)
Kidney cancer (9)
Labor market (22)
Layoffs (244)
Leadership (11)
Legal (1411)
Liver cancer (41)
Longevity (11)
Lung cancer (420)
Lymphoma (251)
Machine learning (24)
Management (7)
Manufacturing (376)
MASH (130)
Medical device (2691)
Medtech (2700)
Mergers & acquisitions (6638)
Metabolic disorders (724)
Multiple sclerosis (102)
NASH (13)
Neurodegenerative disease (230)
Neuropsychiatric disorders (70)
Neuroscience (1952)
Neurotech (1)
NextGen: Class of 2026 (2048)
Non-profit (879)
Now hiring (30)
Obesity (329)
Opinion (126)
Ovarian cancer (131)
Pain (102)
Pancreatic cancer (161)
Parkinson's disease (232)
Partnered (12)
Patents (302)
Patient recruitment (328)
Peanut (43)
People (26723)
Pharmaceutical (44)
Pharmacy benefit managers (6)
Phase 1 (15480)
Phase 2 (20310)
Phase 3 (12889)
Pipeline (3249)
Policy (90)
Postmarket research (856)
Preclinical (6536)
Press Release (30)
Prostate cancer (145)
Psychedelics (50)
Radiopharmaceuticals (238)
Rare diseases (649)
Real estate (1458)
Recruiting (12)
Regulatory (9928)
Reports (19)
Research institute (971)
Resumes & cover letters (18)
Rett syndrome (24)
RNA editing (21)
RSV (17)
Schizophrenia (123)
Series A (182)
Series B (135)
Service/supplier (1)
Sickle cell disease (77)
Special edition (18)
Spinal muscular atrophy (119)
Sponsored (15)
Startups (2009)
State (1)
Stomach cancer (5)
Supply chain (32)
Tariffs (18)
The Weekly (62)
Vaccines (334)
Venture capital (69)
Weight loss (173)
Women's health (26)
Worklife (2)
Date
Last 7 days (344)
Last 30 days (1158)
Last 365 days (17836)
2026 (1654)
2025 (18140)
2024 (20589)
2023 (22459)
2022 (26864)
2021 (27851)
2020 (23401)
2019 (16303)
2018 (11797)
2017 (13773)
2016 (11879)
2015 (14398)
2014 (10439)
2013 (7524)
2012 (7559)
2011 (7654)
2010 (7456)
Location
Africa (155)
Alabama (65)
Alaska (2)
Arizona (73)
Arkansas (5)
Asia (18295)
Australia (3113)
California (7081)
Canada (1842)
China (772)
Colorado (250)
Connecticut (252)
Delaware (244)
Europe (39237)
Florida (903)
Georgia (211)
Hawaii (2)
Idaho (17)
Illinois (396)
India (35)
Indiana (167)
Iowa (8)
Japan (222)
Kansas (80)
Kentucky (9)
Louisiana (7)
Maine (11)
Maryland (738)
Massachusetts (5583)
Michigan (110)
Minnesota (250)
Mississippi (3)
Missouri (32)
Montana (16)
Nebraska (5)
Nevada (33)
New Hampshire (21)
New Jersey (1652)
New Mexico (13)
New York (1761)
North Carolina (827)
North Dakota (6)
Northern California (3475)
Ohio (177)
Oklahoma (11)
Oregon (24)
Pennsylvania (1283)
Puerto Rico (9)
Rhode Island (25)
South America (217)
South Carolina (9)
Southern California (2809)
Tennessee (40)
Texas (905)
United States (23383)
Utah (96)
Virginia (136)
Washington D.C. (37)
Washington State (594)
West Virginia (1)
Wisconsin (45)
282,370 Results for "pearl therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Pearl Diagnostics Announces FDA 510(k) Clearance for Groundbreaking MycoMEIA Aspergillus Urine Assay
August 7, 2025
·
2 min read
Press Releases
Final Data from Teva’s PEARL Real-World Study Reinforce the Long-term Effectiveness of AJOVY® (fremanezumab) for the Prevention of Chronic and Episodic Migraine
June 23, 2025
·
7 min read
Business
Pearl Bio Inks Collaboration with Merck to Discover Novel Engineered Biologics
Pearl Bio today announced that it has entered a license, collaboration and option agreement with Merck, known as MSD outside of the United States and Canada, to discover biologic therapies comprising non-standard amino acids.
March 12, 2024
·
2 min read
Business
Merck Bets Potential $1B on Pearl Bio’s Genomically Recoded Organisms
Synthetic biology company Pearl Bio announced Tuesday it has entered into a license and collaboration agreement with Merck to discover biologic therapies comprising non-standard amino acids.
March 12, 2024
·
2 min read
·
Nick Paul Taylor
Pharm Country
PTC Therapeutics Receives 2023 EURORDIS Black Pearl Company Award for Innovation
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company has been named the winner of 2023 EURORDIS Black Pearl Company Award for Innovation.
February 3, 2023
·
2 min read
Press Releases
NeuroEM Therapeutics(R) Appoints Dr. W. Scott Burgin as Chief Medical Officer
February 1, 2026
·
2 min read
Genetown
Pearl Bio Secures Breakthrough IP for Multi-Functionalized Biologics
Pearl Bio , a synthetic biology company backed by Khosla Ventures, is recoding life to create a new era of biologics and biomaterials.
June 20, 2023
·
2 min read
Press Releases
Cerapedics’ PearlMatrix P-15 Peptide Enhanced Bone Graft, The First and Only Proven Bone Growth Accelerator, Now Approved for Expanded Indications for Use
January 14, 2026
·
6 min read
Press Releases
Cerapedics Announces Publication in Spine of 24-Month ASPIRE Study Results of PearlMatrix™ P-15 Peptide Enhanced Bone Graft
December 18, 2025
·
7 min read
Business
Dr. Pearl Huang Named CEO of Novartis-Backed Dunad Therapeutics (Updated)
Pearl Huang, Ph.D, has been appointed the CEO of U.K.-based Dunad Therapeutics, a Novartis-backed biopharmaceutical startup.
June 28, 2022
·
2 min read
·
Hannah Chudleigh
1 of 28,237
Next
